SOLANA BEACH, Calif., April 24, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (CLPT) (the “Company”), a global device, cell, and gene therapy-enabling company offering precise navigation to the ...
(RTTNews) - ClearPoint Neuro, Inc. (CLPT) announced it has received 510(k) clearance for SmartFrame OR Stereotactic System. Enhanced with the latest OR imaging technology, SmartFrame OR offers ...
SOLANA BEACH, Calif., June 01, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global device, cell, and gene therapy-enabling company offering precise navigation to ...
ClearPoint Neuro, Inc. (Nasdaq:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced it has received 510(k ...
The MarketWatch News Department was not involved in the creation of this content. Record Revenue and Substantial Cash Infusion Highlight the Company's 'Fast. Forward.' Strategy SOLANA BEACH, CA / ...
ClearPoint Neuro (CLPT) on Monday reported preliminary unaudited revenue of approximately $10.4 million for the fourth ...
SOLANA BEACH, Calif., Jan. 16, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (CLPT) (the “Company”), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback